Current Treatment Options in Oncology

Papers
(The TQCC of Current Treatment Options in Oncology is 12. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Role of Metastasis-Directed Therapy in Genitourinary Cancers123
Correction to: Antibody–Drug Conjugate Revolution in Breast Cancer: The Road Ahead91
Selecting Optimal First-Line Treatment for Microsatellite Stable and Non-Mutated RAS/BRAF Metastatic Colorectal Cancer86
Antibody-Drug Conjugates for Melanoma and Other Skin Malignancies81
“Off-the-Shelf” Allogeneic CAR Cell Therapy—Neglected HvG Effect67
Clinical Application of Artificial Intelligence for Non-melanoma Skin Cancer60
Current Approaches of Immune Checkpoint Therapy in Chronic Lymphocytic Leukemia60
Advances in the Pathogenesis, Diagnosis, Treatment, and Prognosis of Marginal Zone Lymphoma57
Current Therapeutic Landscape in Lower Risk Myelodysplastic Syndromes56
The Future of Natural Killer Cell Immunotherapy for B Cell Non-Hodgkin Lymphoma (B Cell NHL)50
An Update on Temporal Bone Paragangliomas48
Small Cell Lung Cancer—An Update on Chemotherapy Resistance48
Chronic Lymphocytic Leukemia: Chemotherapy Free and Other Novel Therapies Including CAR T44
HPV as a Carcinomic Driver in Head and Neck Cancer: a De-escalated Future?42
Options and Considerations in the Management of Peritoneal Disease in Patients with Small Bowel Neuroendocrine Tumors39
Combining Radiotherapy with Immunotherapy in Cervical Cancer: Where Do We Stand and Where Are We Going?39
Enhanced Photodynamic Therapy by Improved Light Energy Capture Efficiency of Porphyrin Photosensitizers38
The Role of Nursing in the Delivery of Cardio-Oncology37
Depression and Long-Term Prescription Opioid Use and Opioid Use Disorder: Implications for Pain Management in Cancer36
Recent Advances in Liver Transplantation for Hepatocellular Carcinoma34
Approach to Localized Squamous Cell Cancer of the Esophagus33
Current Practice in Carcinoid Heart Disease and Burgeoning Opportunities32
Management of Fatigue in Patients with Advanced Cancer32
Regorafenib for the Treatment of Sarcoma31
Targets Selection for Precision Therapy of Relapsed/Refractory Multiple Myeloma: the Latest Advancements31
Revolutionizing Breast Cancer Therapeutics: Intersecting Frontiers of Precision Medicine, Nanotechnology, and Drug Delivery Innovations30
Where Are We Now and Where Might We Be Headed in Understanding and Managing Brain Metastases in Colorectal Cancer Patients?30
Reshaping Treatment Paradigms for Advanced Renal Cell Cancer Patients and Improving Patient Management28
The Review of Modified Intersphincteric Resection in the Treatment of Ultra-Low Rectal Cancer27
Perioperative Immunotherapy in Muscle-Invasive Bladder Cancer27
Advances in Targeted Therapy for Metastatic Prostate Cancer27
Novel Approaches for the Treatment of Patients with Richter’s Syndrome26
Proposals for Clinical Trials in Chronic Myelomonocytic Leukemia26
New Treatment Options for Newly-Diagnosed and Relapsed Chronic Lymphocytic Leukemia25
Optimal Strategies for Colorectal Cancer Screening25
Circulating Tumor DNA in Diffuse Large B-Cell Lymphoma: from Bench to Bedside?24
Recognition and Management of the Long-term Effects of Cranial Radiation24
Steroid Premedication and Monoclonal Antibody Therapy: Should We Reconsider?23
Essential Thrombocythemia in Adolescents and Young Adults: Clinical Aspects, Treatment Options and Unmet Medical Needs23
Treatment Options for Brain Metastases22
Gastric Cancer with Sarcopenia: an Area Worth Focusing On22
Correction to: The Microbiome: the Link to Colorectal Cancer and Research Opportunities22
A Comprehensive Review on the Role of Lurbinectedin in Soft Tissue Sarcomas22
Promising Blood-Based Biomarkers for Melanoma: Recent Progress of Liquid Biopsy and Its Future Perspectives21
Contemporary Review of Adenocarcinoma of the Cervix21
Review of Bone Metastasis in Gynecologic Malignancies: Evaluation and Treatment21
Therapeutic Challenges in the Management of Serous Endometrial Intraepithelial Carcinoma (SEIC)21
Novel Estrogen Receptor-Targeted Agents for Breast Cancer21
Dyadic Interventions for LGBTQ+ Individuals Facing Cancer: A Narrative Review21
Evolution of Treatment Strategies for Gestational Trophoblastic Neoplasia: Chemotherapy, Immunotherapy, and Molecular Targeted Therapy20
New Therapeutic Targets in RAS Wild-type Pancreatic Cancer20
Response Evaluation of Neoadjuvant Therapies in Sarcoma20
R0 Resection in Recurrent Gynecologic Malignancy: Pelvic Exenteration and Beyond20
Emerging DNA Methylome Targets in FLT3-ITD-Positive Acute Myeloid Leukemia: Combination Therapy with Clinically Approved FLT3 Inhibitors19
Approach to Stereotactic Body Radiotherapy for the Treatment of Advanced Hepatocellular Carcinoma in Patients with Child-Pugh B-7 Cirrhosis19
Neoadjuvant Photodynamic Therapy: An Updated Therapeutic Approach for Non-Melanoma Skin Cancers19
New PET Radiotracers for the Imaging of Neuroendocrine Neoplasms19
Research Progress on Ferroptosis in Multiple Myeloma19
Application of Engineered Dendritic Cell Vaccines in Cancer Immunotherapy: Challenges and Opportunities19
Neoadjuvant and Adjuvant Therapy Approaches to Gastric Cancer19
Current Trends in Precision Medicine and Next-Generation Sequencing in Head and Neck Cancer19
One Size Fits Some: Approaching Rare Malignancies of the Urinary Tract19
The Dilemma of Treating Delirium: the Conundrum of Drug Management18
New Developments in Systemic Management for High-Risk Early-Stage Hormone-Receptor-Positive, HER2-Negative Breast Cancer18
Updates in Management of Malignant Pleural Mesothelioma18
Updates in Breast Cancer Screening and Diagnosis18
Advancing Bladder Cancer Management: The Role of Neoadjuvant and Adjuvant Therapies and Biomarkers in Muscle Invasive Bladder Cancer17
What are the Optimal Systemic Treatment Options for Rhabdomyosarcoma?17
Progress in the Treatment of Small Intestine Cancer17
Navigating PARP Inhibitor Resistance in Ovarian Cancer: Bridging Mechanistic Insights To Clinical Translation17
How Genetics Can Drive Initial Therapy Choices for Older Patients with Acute Myeloid Leukemia17
Perioperative Immune Checkpoint Inhibitors for the Treatment of Locally Advanced Gastric and Gastroesophageal Junction Cancer: Current Status and Future Prospects16
New Insights into the Understanding of Mechanisms of Radiation-Induced Heart Disease16
Immunotherapy in the Treatment of Undifferentiated Pleomorphic Sarcoma and Myxofibrosarcoma16
Perioperative Chemotherapy for Liver Metastasis of Colorectal Cancer: Lessons Learned and Future Perspectives16
Treatment of Non-Small Cell Lung Cancer with Atypical EGFR Mutations16
Correction to: Cardiotoxicity of Systemic Melanoma Treatments15
The Role of SIRT1 in Leukemia15
“When Less is More”: Paradigm Shifts in Radiation Treatment for Early-Stage Breast Cancer15
Optimal First-Line Therapy for Metastatic Adenocarcinoma of the Esophagus15
Re-thinking the Role of Thoracic Radiotherapy in the First-Line Treatment for Extensive-Stage Small Cell Lung Cancer15
Myxoid Liposarcomas: Systemic Treatment Options15
Targeting the Renin–angiotensin–aldosterone System (RAAS) for Cardiovascular Protection and Enhanced Oncological Outcomes: Review14
Complex Persistent Opioid Dependence—an Opioid-induced Chronic Pain Syndrome14
Enhancing Colorectal Cancer Treatment Through VEGF/VEGFR Inhibitors and Immunotherapy14
Management and Treatment of Non-small Cell Lung Cancer with MET Alteration and Mechanisms of Resistance14
Taxane-Associated Acute Pain Syndrome: a Review of its Features and Management14
Metastatic Castration-Resistant Prostate Cancer: Advances in Treatment and Symptom Management14
The Role of Induction Therapy for Sinonasal Cancers14
New Developments in Treating RAS-Mutated Metastatic Colorectal Cancer14
Hypnosis for Symptom Management in Adult Cancer Patients: What is the Evidence?14
Advances in PSMA-Targeted Radionuclide Therapeutics14
A Review on Integrating Breast Cancer Clinical Data: A Unified Platform Perspective14
HER2-Positive Metastatic Colorectal Cancer13
Correction to: Recent Advances in Succinate Dehydrogenase Deficient Gastrointestinal Stromal Tumor Systemic Therapies13
Emerging Therapeutic Approaches to Pancreatic Adenocarcinoma: Advances and Future Directions13
RAS and Other Molecular Targets in Pancreatic Cancer: The Next Wave Is Coming13
Correction to: Voluntary Assisted Dying/Euthanasia: Will This Have an Impact on Cancer Care in Future Years?13
ctDNA to Guide Treatment of Colorectal Cancer: Ready for Standard of Care?13
Dermatofibrosarcoma Protuberans (DFSP): Diagnostics and Molecular Pathology13
Management of Functional Pancreatic Neuroendocrine Neoplasms13
Advancements in Melanoma Therapies: From Surgery to Immunotherapy13
The Use of Targeted Agents in the Treatment of Gynecologic Cancers13
Extent of Resection and Outcomes of Patients with Primary Malignant Brain Tumors13
Correction to: Surgical Management and Considerations for Patients with Localized High-Risk Prostate Cancer12
The Improving Outcomes in Relapsed-Refractory Diffuse Large B Cell Lymphoma: The Role of CAR T-Cell Therapy12
Impact of PSMA PET on Prostate Cancer Management12
Immunotherapy for Metastatic Triple Negative Breast Cancer: Current Paradigm and Future Approaches12
Radiotherapy for Advanced Esophageal Cancer: from Palliation to Curation12
Neuroendocrine Tumors: Germline Genetics and Hereditary Syndromes12
Therapeutic Management of Malignant Wounds: An Update12
The Role of Pharmacogenomics in Opioid Prescribing12
Targeted Therapy in Early Stage Non-small Cell Lung Cancer12
0.084999799728394